
Tazray 4000mg/500mg Injection
Marketer
Ritelife Healthcare
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazray 4000mg/500mg Injection
Combiflex 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered exclusively by medical professionals, the dosage and frequency are determined by your physician based on your condition's severity. Strict adherence to prescribed usage is crucial. Commonly reported side effects involve gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver issues to your doctor, who may adjust the dosage or select an alternative medication. Under medical guidance, this injection is generally considered safe during pregnancy and lactation.
Uses of Tazray 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Tazray 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
Common Side effects of Tazray 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazray 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tazray 4000mg/500mg Injection works:
The injectable formulation Tazray, containing 4000mg of Piperacillin and 500mg of Tazobactum, employs a dual-drug mechanism. Piperacillin, an antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby improving Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Tazray 4000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Tazray, 4000mg/500mg, is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no harmful consequences for the fetus; nevertheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Tazray, at a dose of 4000mg/500mg, is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no identified risk to the infant.
DrivingCONSULT YOUR DOCTOR
Tazray 4000mg/500mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Tazray 4000mg/500mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tazray 4000mg/500mg Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification of Tazray 4000mg/500mg Injection may be unnecessary for this population. Physician consultation is recommended.
What if you forget to take Tazray 4000mg/500mg Injection :
Omitting a scheduled dose of Tazray 4000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Tazray 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
